References
- Asbill CS, Michniak BB. (2000). Percutaneous penetration enhancers: local versus transdermal activity. Pharma Sci Technol Today 3:36–41
- Barbero AM, Frasch HF. (2009). Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 23:1–13
- Batheja P, Song Y, Wertz P, Michniak-Kohn B. (2009). Effects of growth conditions on the barrier properties of ahumanskin equivalent. Pharma Res 26:1689–700
- Catz P, Friend DR. (1990). Transdermal delivery of levonorgestrel. VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin, and human skin. Int J Pharma 58:93–102
- Doh HJ, Cho WJ, Yong CS, et al. (2003). Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J Pharma Sci 92:1008–17
- Godin B, Touitou E. (2007). Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 59:1152–61
- Howes D, Guy R, Hadgraft J. (1996). Methods for assessing percutaneous absorption. The report and recommendations of ECVAM Workshop. Altern Lab Anim 24:81–106
- Hadgraft J, Peck J, Williams DG, et al. (1996). Mechanisms of action of skin penetration enhancers/retarders: azone and analogues. Int J Pharma 141:17–25
- Hadgraft J. (2004). Skin deep. Eur J Pharma Biopharma 58:291–9
- Hsieh PW, Al-Suwayeh SA, Fang CL, et al. (2012). The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin. Eur J Pharma Biopharma 81:369–78
- Janůšová B, Skolová B, Tükörová K, et al. (2013). Amino acid derivatives as transdermal permeation enhancers. J Control Release 165:91–100
- Jacobi U, Tassopoulos T, Surber C, Lademann J. (2006). Cutaneous distribution and localization of dyes affected by vehicles all with different lipophilicity. Arch Dermatol Res 297:303–10
- Jacobi U, Kaiser M, Toll R, et al. (2007). Porcine ear skin: an in vitro model for human skin. Skin Res Technol 13:19–24
- Loan Honeywell-Nguyen P, Wouter Groenink HW, Bouwstra JA. (2006). Elastic vesicles as a tool for dermal and transdermal delivery. J Liposome Res 16:273–80
- Li N, Su Q, Tan FP, Zhang J. (2010). Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. Int J Pharma 387:167–71
- Li N, Jia WB, Zhang Y, et al. (2011). Synergistic effect of 1,4-cyclohexanediol and 1,2-hexanediol on percutaneous absorption and penetration of metronidazole. Int J Pharma 415:169–74
- Niazy EM. (1996). Differences in excised rabbit, penetration-enhancing effect of Azone through rat, hairless mouse, guinea pig and human skins. Int J Pharma 130:225–30
- Prausnitz MR, Mitragotri S, Langer R. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115–24
- Qiu YQ, Gao YH, Hu KJ, Li F. (2008). Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release 129:144–50
- Rossetti FC, Lopes LB, Carollo ARH, et al. (2011). A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy. J Control Release 155:400–8
- Simon GA, Maibach HI. (1998). Relevance of hairless mouse as an experimental model of percutaneous penetration in man. Skin Pharmacol Appl Skin Physiol 11:80–6
- Simon GA, Maibach HI. (2000). The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol 13:229–34
- Sarah A, Ibrahim S, Li K. (2009). Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax. J Control Release 136:117–24
- Şenyiğit T, Sonvico F, Barbieri S, et al. (2010). Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 142:368–73
- Tsai YH, Lee KF, Huang YB, et al. (2010). In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system. Int J Pharma 388:257–62
- Wester RC, Maibach HI. (1989). In vivo methods for percutaneous absorption measurements. In: Brounaugh RL, Maibach HI, eds. Percutaneous absorption: mechanisms-methodology-drug delivery, 2nd edn. : Marcel Dekker Inc., 215–37